Eventide Asset Management - UROVANT SCIENCES LTD ownership

UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 22 filers reported holding UROVANT SCIENCES LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of UROVANT SCIENCES LTD
ValueSharesWeighting
Q2 2019$3,176,000
-52.8%
401,558
-40.0%
0.10%
-58.0%
Q1 2019$6,723,000
+52.5%
669,0000.0%0.23%
+18.5%
Q4 2018$4,409,000
-38.2%
669,000
+12.5%
0.20%
-25.6%
Q3 2018$7,138,000594,8160.26%
Other shareholders
UROVANT SCIENCES LTD shareholders Q1 2019
NameSharesValueWeighting ↓
Orchard Capital Management, LLC 191,933$3,096,0001.32%
Beryl Capital Management LLC 351,579$5,671,0000.90%
S. MUOIO & CO. LLC 47,401$765,0000.83%
Kellner Capital, LLC 90,000$1,452,0000.77%
Perceptive Advisors 3,116,831$50,274,0000.54%
GABELLI & Co INVESTMENT ADVISERS, INC. 159,135$2,567,0000.40%
Telemetry Investments, L.L.C. 12,633$204,0000.34%
Yakira Capital Management, Inc. 80,000$1,290,0000.31%
K2 PRINCIPAL FUND, L.P. 146,556$2,364,0000.21%
Wildcat Capital Management, LLC 65,209$1,052,0000.13%
View complete list of UROVANT SCIENCES LTD shareholders